These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 10362120)

  • 1. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent p53 mutations in arsenic-related skin lesions.
    Castrén K; Ranki A; Welsh JA; Vähäkangas KH
    Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH; Robinson RA
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations in human epithelial skin cancers.
    Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
    Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
    Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
    Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
    Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
    J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China.
    Zhang AH; Bin HH; Pan XL; Xi XG
    J Toxicol Environ Health A; 2007 Jun; 70(11):970-5. PubMed ID: 17479413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of mitochondrial DNA D-loop mutations and p53 status in nonmelanoma skin cancer.
    Prior SL; Griffiths AP; Lewis PD
    Br J Dermatol; 2009 Nov; 161(5):1067-71. PubMed ID: 19624548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
    Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
    Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y; Kubo Y; Murao K; Arase S
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
    Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
    Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
    Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
    J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.